IRIS Accounts Production v25.1.0.734 11113839 director 1.1.24 31.12.24 31.12.24 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh111138392023-12-31111138392024-12-31111138392024-01-012024-12-31111138392022-12-31111138392023-01-012023-12-31111138392023-12-3111113839ns15:EnglandWales2024-01-012024-12-3111113839ns14:PoundSterling2024-01-012024-12-3111113839ns10:Director12024-01-012024-12-3111113839ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3111113839ns10:Micro-entities2024-01-012024-12-3111113839ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3111113839ns10:FullAccounts2024-01-012024-12-3111113839ns5:CurrentFinancialInstruments2024-12-3111113839ns5:CurrentFinancialInstruments2023-12-3111113839ns10:RegisteredOffice2024-01-012024-12-31111138391ns10:Director12023-12-31111138391ns10:Director12022-12-31111138391ns10:Director12024-01-012024-12-31111138391ns10:Director12023-01-012023-12-31111138391ns10:Director12024-12-31111138391ns10:Director12023-12-31
REGISTERED NUMBER: 11113839 (England and Wales)







UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

TOFT MEDICAL LIMITED

TOFT MEDICAL LIMITED (REGISTERED NUMBER: 11113839)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024




Page

Balance Sheet 1


TOFT MEDICAL LIMITED (REGISTERED NUMBER: 11113839)

BALANCE SHEET
31 DECEMBER 2024

2024 2023
£    £    £    £   
FIXED ASSETS 281,260 223,363

CURRENT ASSETS 243,904 253,747

CREDITORS
Amounts falling due within one year (67,627 ) (45,749 )
NET CURRENT ASSETS 176,277 207,998
TOTAL ASSETS LESS CURRENT
LIABILITIES

457,537

431,361

CAPITAL AND RESERVES 457,537 431,361

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

Toft Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 11113839

Registered office: Rex Buildings
Alderley Road
Wilmslow
Cheshire
SK9 1HY

2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 3 (2023 - 3 ) .

TOFT MEDICAL LIMITED (REGISTERED NUMBER: 11113839)

BALANCE SHEET - continued
31 DECEMBER 2024

NOTES TO THE FINANCIAL STATEMENTS

3. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 December 2024 and 31 December 2023:

2024 2023
£    £   
Mr N J Toft
Balance outstanding at start of year 151,125 82,283
Amounts advanced 27,745 160,619
Amounts repaid (154,165 ) (91,777 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 24,705 151,125

During the year the company advanced a loan to the director amounting to £24,705. This will be repaid in full within 9 months of the accounting year end. The interest has been charged at the official rate.



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

TOFT MEDICAL LIMITED (REGISTERED NUMBER: 11113839)

BALANCE SHEET - continued
31 DECEMBER 2024


The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 5 May 2025 and were signed by:





Mr N J Toft - Director